9 September 2016Hemostemix (HEM.V) plunges 44% as dissident group nears board takeoverChris Parry Biotech flailer Hemostemix (HEM.V) took a punch to its distended gut today as a sell-off of the embattled stock cut the share price of the company by nearly half,…